Medicina intensiva
-
Apply a sedoanalgesic (SA) protocol for invasive procedures (PI) in pediatric patients and evaluate its effectiveness and safety. ⋯ SA protocol reached its goal of: a) effectiveness: SA achieved was optimal, with amnesia of the procedure in almost all patients and b) safety: complications were controlled due to monitorization and stabilization measurements.
-
To evaluate those procedures in which drug eluting stents DES cannot be implanted and to identify the variables related with this fact. ⋯ In our series, 1.6% of the DES could not be implanted. Some clinical variables, (peripheral arteriopathy) and angiographic (calcium and tortuosity), are associated to a greater risk of this occurring.
-
Review Comparative Study
[Result of extubation after spontaneous breathing test with automatic tube compensation versus continuous positive airway pressure].
The gold standard test to evaluate the readiness of a patient to be extubated is a spontaneous breathing trial. This trial is performed either using the T-piece disconnected from the ventilator, either using a low level of pressure support, with or without positive end-expiratory pressure. ⋯ A major goal to liberate the patient from the ventilator is to recognize the readiness for extubation as soon and as reliably as possible. The stop of sedation and the performance of a spontaneous breathing trial daily diminish the duration of mechanical ventilation due to the recognition of the patient's capability of breathing spontaneously.
-
Anemia is a common condition among medical and surgical patients admitted to the intensive care unit (ICU) and generally has a multifactorial origin. In order to avoid the deleterious effects of anemia, 40% of ICU patients receive allogenic blood transfusion (ABT). ⋯ In contrast, the administration of exogenous erythropoietin plus iron supplements, especially iv iron, improves anemia and reduces ABT requirements, although it does not reduce mortality. To ascertain whether treatment of anemia in the critically ill with exogenous erythropoietin and iron might improve outcomes and to optimize drug administration schedules and dosage, further studies with sufficient statistical power and adequate follow-up are warranted.